TABLE 2.
Target Cell Lines Used in This Study, With HLA-A*02 Status and Representative Quantitative Polymerase Chain Reaction Data for MAGE-A4
| Cell line | Tumor type | Used in figures | HLA-A*02:01 status | MAGE-A4 expression | MAGE-A4 status |
|---|---|---|---|---|---|
| A375 | Malignant melanoma | 1, 3, 5, S4, S6 | + | 1,205,221 | + |
| A375.nucGFP | Malignant melanoma | 2 | + | 1,362,527 | + |
| A375.CopGFP | Malignant melanoma | 4, S7 | + | 729,070 | + |
| Nalm6 | Acute lymphoblastic leukemia | 3, 5, S6 | + | 17 | − |
| Nalm6.nucGFP | Acute lymphoblastic leukemia | 2 | + | 12 | − |
| NCI-H1755 | Non–small cell lung carcinoma | 3, S6 | + | 2,123,084 | + |
| Colo205 | Colorectal carcinoma | 1, S4 | + | 8 | − |
MAGE-A4 expression is presented as normalized transcript number per 106 reference gene transcripts.
MAGE-A4 indicates melanoma-associated antigen A4; S, Supplemental.